» Articles » PMID: 25131707

Meta-analysis and Meta-regression Analysis of Biomarkers for Abdominal Aortic Aneurysm

Overview
Journal Br J Surg
Specialty General Surgery
Date 2014 Aug 19
PMID 25131707
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many studies have investigated the systemic and local expression of biomarkers in patients with abdominal aortic aneurysm (AAA). The natural history of AAA varies between patients, and predictors of the presence and diameter of AAA have not been determined consistently. The aim of this study was to perform a systematic review, meta-analysis and meta-regression of studies comparing biomarkers in patients with and without AAA, with the aim of summarizing the association of identified markers with both AAA presence and size.

Methods And Results: Literature review identified 106 studies suitable for inclusion. Meta-analysis demonstrated a significant difference between matrix metalloproteinase (MMP) 9, tissue inhibitor of matrix metalloproteinase 1, interleukin (IL) 6, C-reactive protein (CRP), α1-antitrypsin, triglycerides, lipoprotein(a), apolipoprotein A and high-density lipoprotein in patients with and without AAA. Although meta-analysis was not possible for MMP-2 in aortic tissue, tumour necrosis factor α, osteoprotegerin, osteopontin, interferon γ, intercellular cell adhesion molecule 1 and vascular cell adhesion molecule 1, systematic review suggested an increase in these biomarkers in patients with AAA. Meta-regression analysis identified a significant positive linear correlation between aortic diameter and CRP level.

Conclusion: A wide variety of biomarkers are dysregulated in patients with AAA, but their clinical value is yet to be established. Future research should focus on the most relevant biomarkers of AAA, and how they could be used clinically.

Citing Articles

Investigating tissue factor pathway inhibitor and other protease and protease inhibitors and their association with major adverse aortic events in patients with abdominal aortic aneurysm.

Khan H, Zamzam A, Shaikh F, Saposnik G, Mamdani M, Qadura M Res Pract Thromb Haemost. 2025; 9(1):102645.

PMID: 39816169 PMC: 11732669. DOI: 10.1016/j.rpth.2024.102645.


Circulating Inflammatory Mediators and Genetic Polymorphisms of Inflammation Mediators and Their Association with Factors Related to Abdominal Aortic Aneurysm: A Systemic Review and Meta-Analysis.

Wang H, Zhong Z, Jiang D, Zhang H, Yin F, Guo P Rev Cardiovasc Med. 2024; 23(8):270.

PMID: 39076643 PMC: 11266967. DOI: 10.31083/j.rcm2308270.


Brazilian Society for Angiology and Vascular Surgery guidelines on abdominal aortic aneurysm.

Mulatti G, Joviliano E, Pereira A, Fioranelli A, Pereira A, Brito-Queiroz A J Vasc Bras. 2023; 22:e20230040.

PMID: 38021279 PMC: 10648059. DOI: 10.1590/1677-5449.202300402.


C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms.

Fu Y, Liu H, Li K, Wei P, Alam N, Deng J Front Immunol. 2023; 14:1233807.

PMID: 37753091 PMC: 10518468. DOI: 10.3389/fimmu.2023.1233807.


Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm.

Bouwens E, Vanmaele A, Hoeks S, Verhagen H, Fioole B, Moelker A Vasc Med. 2023; 28(5):433-442.

PMID: 37395286 PMC: 10559648. DOI: 10.1177/1358863X231181159.